The Chinese Food and Drug Administration (CFDA) has issued a new “Medical Equipment Generic Naming Guide,” which will be implemented on April 1, 2016. This is the first regulatory document for ‘naming’ generic medical devices. The CFDA believes this move is significantly important to improve China’s medical device regulatory system and infrastructure.
Per the new regulations, all medical equipment generic names will have to be in Chinese and in line with the national language specifications. Medical devices that have the same or similar function and/or utilize the same technology will have to use the same generic name, a common name that consists of a core word and no more than three specifications.
Some of the additional rules prohibit generic medical device manufacturers to list:
- Model, specification, graphic, symbol and etc.(“型号、规格”、“图形、符号等标志).
- Personal name, company name, registered Trademark, etc. (“人名、企业名称、注册商标或者其他类似名称”).
- Words such as best, only, precise, quick, absolute, or other exclusive words (“最佳、唯一、精确、速效等绝对化、排他性的词语”).
- Efficiency, cure rate (“说明有效率、治愈率的用语”).
Based on this new regulation, along with some of the other recent regulatory changes being made at the CFDA (Refer to RegDesk blogs below), the future of medical device importation into the Chinese market appears dim and difficult.
RegDesk is an A.I.-powered regulatory intelligence software that offers 24/7 access to the latest regulatory information for over 50 markets worldwide. Our platform eliminates the need for medical device companies to spend months gathering intelligence and preparing their registration applications. Through RegDesk’s centralized platform, clients can get access to product-specific registration requirements, expert answers to their most critical regulatory questions, and real-time alerts about global regulatory changes. To experience the power of RegDesk, contact us at firstname.lastname@example.org or visit www.regdesk.co.